Norihiro Murakami
Overview
Explore the profile of Norihiro Murakami including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
299
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yoshida T, Muramatsu H, Wakamatsu M, Sajiki D, Murakami N, Kitazawa H, et al.
Haematologica
. 2023 May;
108(11):3115-3119.
PMID: 37226702
No abstract available.
2.
Sakai T, Okuno Y, Murakami N, Shimoyama Y, Imagama S, Nishida Y
Front Oncol
. 2023 Jan;
12:956472.
PMID: 36686800
Phosphaturic mesenchymal tumor (PMT) is a rare tumor that secretes fibroblast growth factor 23 (FGF23) and causes hypophosphatemia and tumor-induced osteomalacia (TIO). Fusion genes and have been detected in some...
3.
Imaizumi T, Meyer J, Wakamatsu M, Kitazawa H, Murakami N, Okuno Y, et al.
Sci Rep
. 2022 Aug;
12(1):14753.
PMID: 36042365
Juvenile myelomonocytic leukemia (JMML) is a rare heterogeneous hematological malignancy of early childhood characterized by causative RAS pathway mutations. Classifying patients with JMML using global DNA methylation profiles is useful...
4.
Kitazawa H, Okuno Y, Muramatsu H, Aoki K, Murakami N, Wakamatsu M, et al.
Blood Adv
. 2021 Sep;
5(24):5507-5518.
PMID: 34580726
Juvenile myelomonocytic leukemia (JMML) is a rare myelodysplastic/myeloproliferative neoplasm that develops during infancy and early childhood. The array-based international consensus definition of DNA methylation has recently classified patients with JMML...
5.
Ichikawa D, Yamashita K, Okuno Y, Muramatsu H, Murakami N, Suzuki K, et al.
NPJ Genom Med
. 2021 Jun;
6(1):49.
PMID: 34131151
Pediatric solid tumors are a heterogeneous group of neoplasms with over 100 subtypes. Clinical and histopathological diagnosis remains challenging due to the overlapping morphological and immunohistochemical findings and the presence...
6.
Kataoka S, Kawashima N, Okuno Y, Muramatsu H, Miwata S, Narita K, et al.
J Allergy Clin Immunol
. 2021 Mar;
148(2):639-644.
PMID: 33727065
Background: Type I interferonopathies are a recently established subgroup of autoinflammatory diseases caused by mutations in genes associated with proteasome degradation or cytoplasmic RNA- and DNA-sensing pathways. Objective: This study...
7.
Schonung M, Meyer J, Nollke P, Olshen A, Hartmann M, Murakami N, et al.
Clin Cancer Res
. 2020 Nov;
27(1):158-168.
PMID: 33139265
Purpose: Known clinical and genetic markers have limitations in predicting disease course and outcome in juvenile myelomonocytic leukemia (JMML). DNA methylation patterns in JMML have correlated with outcome across multiple...
8.
Wakamatsu M, Okuno Y, Murakami N, Miwata S, Kitazawa H, Narita K, et al.
Leukemia
. 2020 Apr;
35(1):259-263.
PMID: 32307441
No abstract available.
9.
Murakami N, Sakai T, Arai E, Muramatsu H, Ichikawa D, Asai S, et al.
Haematologica
. 2019 Jun;
105(2):e61-e64.
PMID: 31171640
No abstract available.
10.
Okuno Y, Murata T, Sato Y, Muramatsu H, Ito Y, Watanabe T, et al.
Nat Microbiol
. 2019 Feb;
4(3):544.
PMID: 30705423
In the version of this Letter originally published, in the sentence beginning "The major driver role of DDX3X mutations...", the citation "Fig. 2a-f" should have been "Fig. 2". In addition,...